...
机译:溶剂控制的,位点 - 选择性氮杂稠环环杂环在N1-,N 2和N 3 - 位置,包括吡唑[3,4- D i >]嘧啶,嘌呤,[1,2,3]三亚唑[4,5]吡啶,以及相关的Deaza-化合物
Departments of Medicinal Chemistry Structural Biology and Scientific Computing;
Departments of Medicinal Chemistry Structural Biology and Scientific Computing;
Departments of Medicinal Chemistry Structural Biology and Scientific Computing;
Departments of Medicinal Chemistry Structural Biology and Scientific Computing;
Departments of Medicinal Chemistry Structural Biology and Scientific Computing;
Departments of Medicinal Chemistry Structural Biology and Scientific Computing;
Departments of Medicinal Chemistry Structural Biology and Scientific Computing;
Department of Chemistry Crystallography Laboratory University of California;
Department of Chemistry Crystallography Laboratory University of California;
Departments of Medicinal Chemistry Structural Biology and Scientific Computing;
机译:溶剂控制的,位点 - 选择性氮杂稠环环杂环在N1-,N 2和N 3 - 位置,包括吡唑[3,4- D i >]嘧啶,嘌呤,[1,2,3]三亚唑[4,5]吡啶,以及相关的Deaza-化合物
机译:氰基酰胺作为吡咯并[[3,4-d]嘧啶-4-酮,2-ARYL-6取代的1,2,3-三唑并[[4,5-d]]嘧啶和吡唑并[1,5]前体的用途-a]嘧啶-3-羧酰胺
机译:吡唑并[3,4-d] [1,2,3]三唑并[1,5-a]嘧啶:通过Dimroth重排的新环系统